Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease
Summary by Ground News
Cardiosense, Inc. has raised $15.1 million in Series A funding. The capital will be used to support team expansion, accelerate product development, and fund an expansive heart failure study. The Company's first clinical application focuses on improving the management of congestive heart failure (CHF)Published 2 months ago · Chicago, United States
News Articles
More Filters
All
Left
Center
Right
Similar News Topics
Time & Location
Sources are mostly out of (0)